Comment from mark Villeneuve

Summary: Mark E. Villeneuve, a patient living with Mycosis Fungoides, supports the Haystack Project Petition to modernize the regulatory framework for rare disease treatments. He argues that the current system should be updated to recognize clinically meaningful endpoints and unique study designs that reflect the realities of rare diseases without lowering safety and effectiveness standards.